The oncolytic virus therapy landscape has expanded steadily over the past decade, with over 100 companies worldwide pursuing clinical or preclinical programs. A few leaders, such as Candel Therapeutic ...

DelveInsight's Oncolytic Virus Competitive Landscape 2026 report provides comprehensive global coverage of pipeline oncolytic ...

A new randomized clinical trial showed that receiving immunochemotherapy infusions earlier in the day may help patients with ...

Kazia Therapeutics , an oncology-focused pharmaceutical company developing novel therapies for difficult-to-treat cancers, ...

Copper is an essential cofactor for all organisms. However, it can become toxic if its concentration rises above a specific level. This level is controlled by evolutionary conserved homeostatic ...

Q3 FY2025 Earnings Call January 29, 2026 5:30 AM EST Shinichiro Muraoka - Morgan Stanley, Research Division Hidemaru Yamaguchi - Citigroup Inc., Research Division Stephen Barker - Jefferies LLC, ...

Cell division is a fundamental process that allows cells to replicate accurately and maintain tissue homeostasis. This ...

The authors present convincing data to validate abscisic acid-induced dimerisation to induce a synthetic spindle assembly checkpoint (SAC) arrest that will be of particular importance to analyse ...

Detailed price information for Biovaxys Technology Corp (BVAXF) from The Globe and Mail including charting and trades.